Michael A Fournel

Title: The Innovative Contributions of Michael A. Fournel

Introduction

Michael A. Fournel is a notable inventor based in Castro Valley, California. He has made significant contributions to the field of biotechnology, particularly in the evaluation of immunogenicity of proteins derived from recombinant DNA technology. With a total of three patents to his name, Fournel's work has implications for vaccine development and therapeutic proteins.

Latest Patents

Fournel's latest patents include a method for evaluating the potential immunogenicity of a protein derived from recombinant DNA technology. This method involves injecting an animal with the recombinant protein and isolating antiserum from the animal. The antiserum is then depleted of antibodies to a reference protein, which is a plasma-derived protein, by adsorbing the antiserum against the reference protein. The adsorbed antiserum is subsequently blotted against the recombinant protein to determine if any antibodies were produced that recognize the recombinant protein but did not recognize the plasma-derived protein during adsorption.

Career Highlights

Throughout his career, Michael A. Fournel has worked with prominent companies in the biotechnology sector, including Miles Inc. and Cutter Laboratories, Inc. His experience in these organizations has contributed to his expertise in immunogenicity evaluation and protein analysis.

Collaborations

Fournel has collaborated with notable professionals in his field, including Pamela C. Esmon and Paul K. Ng. These collaborations have likely enriched his research and development efforts.

Conclusion

Michael A. Fournel's innovative work in evaluating immunogenicity has made a significant impact in biotechnology. His patents and collaborations reflect his dedication to advancing the field and improving therapeutic solutions.